No, a doctor cannot write a retatrutide prescription yet. Retatrutide is not FDA approved, so there is no routine prescribing pathway. InCare and Doctronic both say the legal way to get it now is through a clinical trial.
Why a doctor can’t prescribe retatrutide yet
Retatrutide is not FDA approved, so it has no routine prescribing pathway, according to InCare and Doctronic. Doctronic’s explainer, updated July 23, 2026, says that as of August 2026 retatrutide is investigational and available only in clinical trials, and that no licensed provider can prescribe it outside a trial. Doctronic reports that Eli Lilly, the maker, plans to file for FDA approval in early 2027, and says approval may come in late 2027 or later. Treat that timing as Doctronic’s estimate, not a date from Lilly or FDA.
The FDA’s FDA page on illegally sold diabetes treatments warns that unproven diabetes products are sold online and in stores, and advises checking with your health care professional before buying one.
How to get retatrutide legally: a clinical trial
InCare and Doctronic both name a clinical trial as the legal route right now. The NIH’s NIDDK diabetes page on clinical studies says that federally funded, open, recruiting studies are listed on ClinicalTrials.gov, and that you can widen the list to include industry-sponsored studies. It also says the NIH does not review those industry studies and cannot ensure they are safe for you, so talk with your health care professional before you join one.
Here is how to go about it:
- Search ClinicalTrials.gov for retatrutide studies that are recruiting and close to you.
- Read the eligibility criteria. Trials have strict health and demographic requirements, and enrollment is limited.
- Bring the study to your primary care doctor before you apply.
- Contact the trial site directly for screening details.
- Ask how you will be monitored. Trial participants are closely observed for safety.
To see what a trial involves, look at the TRIUMPH-Outcomes listing on ClinicalTrials.gov. It is a Phase 3 study of retatrutide, planned for 10,000 participants, for adults with a BMI of 27 or higher and atherosclerotic cardiovascular disease and/or chronic kidney disease. It runs about five years, with up to 27 clinic visits. Its status is active, not recruiting, so it shows you the format rather than an open door.
Can you get retatrutide from a compounding pharmacy or an online seller?
InCare’s guide says compounding under the shortage-based pathway requires an approved reference product, and retatrutide has none, so it cannot be compounded that way. Doctronic’s explainer says FDA has issued warning letters to multiple sellers, and that products sold as retatrutide cannot be verified. They may contain a different peptide, no active ingredient, or the wrong dose, and they have no manufacturing oversight. If a clinic or website promises quick access with no medical screening, treat that as a warning sign.
What is still unknown
Doctronic notes that long-term safety beyond two years has not been established. Final dosing will not be known until FDA reviews the data and approves a label, Doctronic says. Approval timing is the biggest open question, and FDA makes that decision.
What side effects have been reported in the trials?
Doctronic and InCare both list nausea, diarrhea, constipation and vomiting as the most common side effects in the trials. Doctronic describes them as usually mild to moderate and most noticeable during dose increases. Safety is still being studied, and long-term safety beyond two years has not been established. For the safety picture that applies to you, ask your doctor how trial safety data would apply to your health history, and check FDA’s own announcements when they come.
What to ask your doctor now
Bring these questions to your next visit:
- Is there a retatrutide trial near me, and do I meet its eligibility criteria?
- Which FDA-approved weight-management medicines would you consider for me today?
- How do my current conditions and medicines affect trial eligibility?
- Which recent weight, blood pressure and lab numbers should I have ready if I am screened?
If you already take a diabetes medicine, our metformin side effects guide shows the symptoms worth bringing to your doctor.
Your next step
This week, search ClinicalTrials.gov for retatrutide, write down any recruiting study near you, and bring that list to your next appointment.
By the Primary Care Visit Guide Team
Leave a Reply